Joris van Dam retweeted
The New England Journal of Medicine has published results from BLUE-C, the pivotal trial evaluating the performance of our next-generation Cologuard® test. Read the press release: bit.ly/3vhkkWb @NEJM
Joris van Dam retweeted
Whoa! @AllofUsResearch is hiring a Chief User Experience Officer, to lead all aspects of user-centered design! @AllofUsResearch already has 535,000+ individuals (heading to 1 million+) contributing biospecimens & surveys… already one of the largest biomed cohorts in the world!
Spread the word!
This Post is from an account that no longer exists. Learn more
Joris van Dam retweeted
Today we announced our preliminary Q4 results. For more information, see our press release here: ms.spr.ly/6012ilyfm
Many thanks again to our partners and friends at MAPS and at OM1 for hosting an exciting discussion on accelerating the translation of medical innovation with #realworlddata and #realworldevidence !
Today's MAPS Webinar with @Om1Inc "Shifting the Paradigm (and Price) on Integrated Evidence Generation" is NOW AVAILABLE at the MAPS Content Hub!
Watch this event HERE: medicalaffairs.org/shifting-…
#MedicalAffairs #MedAffairs #MAPSEvent #jointhemovement
Joris van Dam retweeted
We’re excited to share our Q2 earnings. Read more about the strong results here: exas.co/44HsHXH
Joris van Dam retweeted
We’re thrilled to announce results from BLUE-C, our pivotal trial to evaluate the performance of our next-generation Cologuard® test. The results show that the test met all study endpoints & improved on every top-line metric from Cologuard. Read more: exas.co/3pdSAyR
BLUE-C Study Top-Line Results
The field of Digital Therapeutics stands on the shoulders of giants, and it's been an absolute privilege to publish many of their perspectives in this edited volume.
📣It’s Publication Day
🚨New Book🚨Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects ed. @DamJoris @OleksandrSverdlov
@glicholai (@HarvardHBS) and I wrote about #Digital #Therapeutics and #Privacy #Data routledge.com/Digital-Therap…
Digital Phenotyping: using data from smart devices and wearables to personalize digital health interventions. A fascinating overview of recent progress and future opportunities. #digitalhealth #digitalphenotyping #wearables bioinform.jmir.org/2022/1/e3…
Amazing research from @benbendc presents framework to super-power human performance in healthcare with AI #HXD2022 hcil.umd.edu/human-centered-…
"we need to change the discussion from data privacy to data governance". Well said @AndreaCoravos - give users the tools to choose and decide not the rules to decide or protect on their behalves.
Joris van Dam retweeted
Katie Couric sits down with CEO Kevin Conroy to discuss our mission to eradicate cancer and how our teams are working to make it possible to detect cancers earlier. ms.spr.ly/6018Xgb4u @katiecouric
Yes!
Replying to @FIH_Hockey
FT🇦🇺1-1🇧🇪 2-3 after shoot-out
BELGIUM ARE THE OLYMPIC GOLD MEDALLISTS! Vincent Vanasch is BEL's hero yet again, denying Govers, Simmonds & Whetton twice following a re-take. Tears of joy from @BELRedLions
Match info: bit.ly/3xteCM5
#olympics #hockey #AUSvBEL
Joris van Dam retweeted
Our next chapter begins today. We are pleased to announce we have entered into an agreement to become a public company through a business combination with the SPAC @thimblepoint, which is expected to close in the second half of 2021. bit.ly/35JziUA #digitalhealth
Excited to share that I will be joining the @ColumbiaExecEd module in #ManagingDTX #DigitalHealth #Strategy-- April 6-15th provided in a distance learning format, click here to learn more: www8.gsb.columbia.edu/execed… #ExecutiveEducation #HealthTech













